SAN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits ...
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
The MARCAP Consortium is the largest independent data repository and statistical analysis team, with Dr. Spratt and Dr. Amar Kishan as co-primary investigators. The purpose of the first MARCAP ...
CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
New research from China suggests that applying a 125 mg dose of testosterone gel makes men more likely to mimic the behaviors ...
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery — the ...
UFC legend Vitor Belfort suffered from the banning of testosterone replacement therapy, says commentator Joe Rogan.
PCOS affects up to 13% of women of reproductive age and increases the risk for type 2 diabetes, cardiovascular diseases, ...
The firm said it found its antibody-drug conjugate payload had activity as both a monotherapy and in combination with androgen receptor inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback